michigan glp-1 gastroparesis law firm The legal battle is heating up. Novo Nordisk sued Hims & Hers after the telehealth company announced plans to sell a compounded oral GLP-1 pill positioned as a lower-cost alternative to Ozempic Lawsuit Lawyer | Gastrointestinal

This translates to a compound annual growth rate (CAGR) of 21.65% from 2024 to 2030

See what others like you are saying

Patients report developing serious eye problems such as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), which can cause sudden and irreversible blindness

Clinical trials have demonstrated substantial weight loss with semaglutide

This federal multidistrict litigation streamlines the Ozempic litigation process, allowing plaintiffs to share evidence, coordinate expert witnesses, and build stronger cases together

It also lowered the secretion of cytokines IL-5 and IL-13 that belong to type 2 inflammation by ILC2s, suggesting that GLP-1R signaling may inhibit innate allergic immune responses in the lung [135]